Hydrocodone Classification: TMA supports the classification of hydrocodone as a Schedule III, not a Schedule II, drug (Res. 304-A-04; amended CSPH Rep. 2-A-14 and reaffirmed Res. 310-A-14).
October 07, 2016
What could a TMA Membership mean for you, your practice, and your patients
Incoming TMA President David Fleeger, MD, sets his sights on protecting the patient-physician relationship from corporate intrusion and equipping physicians for sea changes affecting medicine. Plus ... TMA's 2018 Survey of Texas Physicians is here with doctors speaking their minds on legislative priorities, payer relations, practice environment and much more. Read the Latest Issue